We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong at PhilMedical 2023 Expo | More to Expect!

By LabMedica International staff writers
Posted on 19 Sep 2023
From 23 to 25 August 2023, the MEDICAL PHILIPPINES 2023 Expo was held at the SMX Convention Center in Manila, Philippines. More...
As the largest and most professional medical devices expo in Philippines, it attracted the participation of many famous companies in the industry. As an innovative leader in the field of molecular diagnostics in China, Tianlong Technology showcased its advanced technology, products and solutions, as well as professional services on this expo.

At the exhibition, Tianlong’s Panall 8000 All-in-one Molecular Diagnosis System, which can realize "joint detection of multiple pathogens", the compact and flexible Gentier Mini Series Portable Real Time PCR System, as well as the GeneFlex Automatic Nucleic Acid Extractor, received wide attention from the visitors.

On the first day of the expo, the head of Department of Emergency Medical and Trauma Services, Hospital Kuala Lumpur visited Tianlong’s booth and had a deep communication with Tianlong processionals. Hospital Kuala Lumpur is now the largest hospital under the Ministry of Health of Malaysia and is considered to be one of the biggest hospital in Asia.

During the expo, Tianlong's professional team had deep communication with customers, introducing and demonstrating product features, technical advantages and service system.

Tianlong not only achieved good attention on the exhibition, but also developed cooperation opportunities, opening up new channels and opportunities for the future development of the enterprise.

The successful participation in the expo is also an important step in Tianlong's globalization strategy. As an enterprise actively expanding overseas markets, Tianlong will continue to look at the global market and work with more international partners to promote the development of medical technology.

Stay tuned for Tianlong’s following two expos in Thailand this coming September!

Thailand LAB International
Booth No. 3G17
Dates: Sep 6 to 8, 2023
Venue: BITEC, Bangkok, Thailand

Medical Fair Thailand
Booth No. T05
Dates: Sep 13 to 15, 2023
Venue: BITEC, Bangkok, Thailand



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Automatic CLIA Analyzer
Shine i6000
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.